Development of Monoclonal Antibody Anti-African Bitis arietans Snake Toxin Phospholipase A2
Journal Title: Journal of Toxins - Year 2017, Vol 4, Issue 1
Abstract
This work is part of long-term research to improve the quality of antivenom antibodies based on cumulative information gathered from established knowledge of the immune response cellular and molecular mechanisms as well as from molecular animal venom toxins. There are two main objectives: first, the introduction of punctual modifications to antitoxin antibody (Ab) production for immediate use; second, the use of Ab hyper variable regions to model scFvs that have high toxin neutralizing potency. The first objective has been successfully accomplished in recent years. Polyclonal Abs (pAbs) that has high antigen (Ag) potency recognition has been developed. For the second objective, the use of purified-characterized toxins as antigens to produce monoclonal Abs (mAbs) is ongoing. This manuscript contains data indicating that purified and enzymatically characterized PLA2 from Bitis arietans venom induces IgA mAbs that recognize epitopes and neutralize toxic domains with desirable potency. The obtained mAb will serve as a hypervariable sequence source for single chain fragments variable (scFvs). The present study highlights the use of purified venom toxins as substitutes for complete venoms in immunization procedures.
Authors and Affiliations
Wilmar Dias da Silva
Keywords
Related Articles
- EP ID EP246749
- DOI 10.13188/2328-1723.1000020
- Views 117
- Downloads 0
Chemoprevention of Silymarin and Vitamin C on Isoniazid-Induced Hepatotoxicity in Experimental Rat Model
Isoniazid, anti-mycobacterial agent employed clinically in the treatment of bacterial infections (tuberculosis), is known to cause a number of biochemical dysfunctions and suspected to induce hepatic damage to animals an...
Insecticide Reproductive Toxicity Profile: Organophosphate, Carbamate and Pyrethroids
Exposure to pesticides is very common world-wide, and is broadly known the acute toxic effects to humans of pesticides following a high dose exposure; however, knowledge about chronic low-dose adverse effects to specific...
Development of Monoclonal Antibody Anti-African Bitis arietans Snake Toxin Phospholipase A2
This work is part of long-term research to improve the quality of antivenom antibodies based on cumulative information gathered from established knowledge of the immune response cellular and molecular mechanisms as well...
Geographic Variation in the Peptidome Fraction of the Venom of Naja naja naja (Indian Cobra) Species as Analysed by MALDITOF; Implications on Antivenin Development
Purpose: Several studies have shown that the commercially available antivenoms are ineffective in neutralizing the toxic and lethal effects. In this study, we aimed at analysing the comparative peptidome fractions of ven...
Isolation and Characterization ofa Myotoxic Fraction from Cerastes Vipera Snake Venom
The aim of this study was to evaluate the biological effects of crude Cerastes vipera venom and some phospholipase A 2 (PLA 2 ) activity containing fraction (CV-PL-F 4 ). Furthermore, the current study examined the antim...